Ordering
Available Variants10 mg
CHA.19914-10mg
Price
€229.60
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
10 mg | CHA.19914-10mg | €229.60 |
phyproof® Reference Substance
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C11H14N2O |
|---|---|
| CAS Number | 485-35-8 |
| Molecular Weight | 190.24 |
| UNSPSC Code | 41116107 |
| NACRES | NA.24 |
| EC Number | 207-616-0 |
| MDL number | MFCD00136048 |
Safety Information Handling visibility
| pictograms |
GHS06
 GHS06
|
|---|---|
| signalword | Danger |
| hcodes | H301 + H311 + H331 |
| pcodes | P280 - P301 + P310 + P330 - P302 + P352 + P312 - P304 + P340 + P311 |
| Hazard Classifications | Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral |
| Storage Class | 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects |
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
Cytisine, with the chemical formula C10H12N2 and CAS number 485-35-8, is a naturally occurring quinolizidine alkaloid found in various plant species, particularly in the genus Cytisus. It has been identified as a partial agonist of the nicotinic acetylcholine receptor, exhibiting a high affinity for these receptors. Cytisine has been investigated for its potential therapeutic applications, including the treatment of nicotine addiction and other neurological disorders. Its mechanism of action involves the modulation of nicotinic acetylcholine receptors, which play a crucial role in various physiological processes, including cognition, memory, and neurotransmission. The compound has shown promise in preclinical studies, demonstrating efficacy in reducing nicotine cravings and withdrawal symptoms, and its unique pharmacological profile warrants further research into its clinical potential. Further studies are needed to fully elucidate its effects and potential therapeutic uses.
